Home > Education & Research > Research to Improve Health Care > Participating in Research > Clinical Trials > Clinical Trials Details
<< Back to Results
This is a phase 2 multicenter, randomized, placebo-controlled, double-blind, parallel-group, 36-month clinical trial to evaluate the effectiveness and safety of intervention with a 12-month course of Hydroxychloroquine to prevent the future onset of clinically-apparent Rheumatoid Arthritis.
Essentia Health Duluth
For more information about a financial conflict of interest (FCOI), review the Essentia Health FCOI policy.